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ABSTRACT
PDT is widely applied for the treatment of non-melanoma skin cancer pre-
malignant and malignant lesions (actinic keratosis, basal cell carcinoma and in 
situ squamous cell carcinoma). In photodynamic therapy (PDT) the interaction 
of a photosensitizer (PS), light and oxygen leads to the formation of reactive 
oxygen species (ROS) and thus the selective tumor cells eradication. Xeroderma 
pigmentosum (XP) and Gorlin-Goltz Syndrome (GS) patients are at high risk of 
developing skin cancer in sun-exposed areas. Therefore, the use of PDT as a 
preventive treatment may constitute a very promising therapeutic modality for 
these syndromes. Given the demonstrated role of cancer associated fibroblasts 
(CAFs) in tumor progression and the putative CAFs features of some cancer-
prone genodermatoses fibroblasts, in this study, we have further characterized 
the phenotype of XP and GS dermal fibroblasts and evaluated their response to 
methyl-δ-aminolevulinic acid (MAL)-PDT compared to that of dermal fibroblasts 
obtained from healthy donors. We show here that XP/GS fibroblasts display clear 
features of CAFs and present a significantly higher response to PDT, even after 
being stimulated with UV light, underscoring the value of this therapeutic approach 
for these rare skin conditions and likely to other forms of skin cancer were CAFs 
play a major role.
INTRODUCTION
Ultraviolet radiation (UVR) from sun is the major 
etiologic factor responsible for skin cancer. Apart from 
the local immunosuppressive effects, UVA and UVB 
can induce DNA damage directly or through reactive 
oxygen species (ROS) production. Damaged cells, if 
not correctly repaired or eliminated, may survive with 
genetic alterations, causing aging and cancer [1–3]. 
Skin overexposure to UVR results in clearly mutagenic 
DNA lesions, being pyrimidine photoproducts such as 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine 
(6-4) pyrimidone photoproducts (6-4PPs) the predominant 
forms of DNA adducts [3, 4].
The harmful effects caused by UVR overexposure 
on human skin are particularly relevant in patients 
with specific genetic disorders which lead to UV-light 
sensitivity. This is the case of Xeroderma pigmentosum 
(XP) and Gorlin-Goltz syndrome patients. Xeroderma 
pigmentosum (XP) is a rare, autosomal, recessive, 
genetic disorder that occurs as a result of mutations 
in genes involved in the nucleotide excision repair 
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(NER) pathway, making defective the responses of XP 
cells to photoproducts induced in DNA by UVR from 
sunlight. Patients with this syndrome have a very high 
predisposition for developing skin cancers in sun-exposed 
areas due to this diminished DNA repair activity [2, 5, 
6]. XP patients develop both non-melanocytic cancer 
(squamous cell carcinomas, SCCs; and basal cells 
carcinomas, BCCs) and malignant melanoma with a 
frequency higher than 10000 and 2000 fold respectively 
than in the general population [6]. Gorlin-Goltz syndrome 
(GS), also known as nevoid basal cell carcinoma syndrome 
(NBCCS), is a genetic disorder inherited in a dominant 
autosomal way whose patients are predisposing to develop 
multiple (from several to thousands) BCCs. Mutations in 
genes of Hedgehog pathway has been identified as the 
cause of this syndrome. Most mutations occur in Patched 
(PTCH 1) gene, although can also occur in Smoothened 
(SMO) gene [7–10].
A strict protection regimen from sunlight combined 
with conventional surgery or cryotherapy is the mainstay 
of traditional treatment of these syndromes. However, 
because of 90% of lesions are located in sun-exposed 
sites such as face or neck, it can result in a significant 
disfigurement [6, 2, 11]. Moreover, in many cases, the 
large number of lesions in the same area makes traditional 
therapeutic modalities impractical [12].
In this sense, photodynamic therapy (PDT), a non-
invasive modality widely used in dermatology mainly 
for the treatment of some variants of non-melanoma 
skin cancer (NMSC), has the advantage of achieving a 
good cosmetic outcome. PDT is based on the interaction 
of a photosensitizer (PS), light and oxygen, that leads 
to the formation of ROS and thus the eradication of 
treated lesion [13, 14]. ROS are extremely harmful for 
cell viability. Their intracellular accumulation cause 
the oxidation and subsequent functional inactivation of 
several cell components and can also severely disturbing 
DNA replication and transcription mechanisms. All these 
processes can activate irreversible apoptotic and necrotic 
cell death mechanisms and the induced oxidative stress is 
associated with several human diseases [15, 16].
The possibility of using PDT as a preventive 
treatment for XP and GS syndromes constitutes a very 
interesting research area. Larson and Cunninghan [17] 
reported good results applying PDT to affected areas in a 
patient with XP. Furthermore, clinical studies carried out 
by Segura et al. [18] showed that topical PDT with MAL 
and red light may be useful for the treatment of superficial 
BCC in GS and XP patients.
There are many evidences indicating that tumor 
microenvironment plays a prominent role in the onset, 
growth, and proliferation of neoplastic cells. Cancer cells 
can activate their stroma and trigger the remodeling of 
extracellular matrix (ECM) promoting tumor growth. 
Moreover, the tumor microenvironment can also generate 
oxidative damage and genetic instability, stimulating 
invasive capacity of cancer cells [19–21]. In this context, 
dermal fibroblasts obtained from skin biopsies of patients 
with XP or GS syndromes would be a key determinant in 
investigating factors involved in the malignant progression 
and spread of skin cancer and could represent an important 
target for novel cancer therapies.
This study mainly focused on evaluating the effects 
of MAL-PDT on primary dermal fibroblasts from XP and 
GS patients. We have analyzed the possible differences in 
their responses to the treatment and then have compared 
them to the response in healthy fibroblasts. Moreover, we 
have also assessed whether the effects of MAL-PDT were 
sustained when these fibroblasts were stimulated with UVA 
and UVB light at sub-genotoxic doses. It can be expected 
that XP and GS fibroblasts show characteristics of cancer-
associated fibroblasts (CAFs), playing an important role 
in several aspects of the tumor progression, promoting 
cancer cell growth, invasiveness and angiogenesis [19, 
22, 23], so they could be excellent potential targets for 
PDT to prevent the appearance of skin cancer in XP and 
GS patients.
RESULTS
Characterization of XP and GS fibroblasts: 
analysis of CAFs markers
To characterize the putative CAF features of 
fibroblasts obtained from XP and GS donors, we evaluated 
the protein expression pattern (Figure 1A) and the intensity 
of the fluorescent signal (Figure 1B) of α-sma, vinculin/F-
actin, vimentin and endoglin by immunofluorescence. 
Analysis of α-sma revealed a significantly stronger signal 
in GF and XF compared to CF (P<0.01). Differences 
were also evident regarding α-sma expression pattern: 
well organized and arranged in visible fibers in XF and 
GF, while diffused in the cytoplasm in CF. Fluorescent 
signal of vinculin, a protein involved in the regulation of 
focal adhesions (FAs), was significantly more intense in 
GF than in XF and CF (P<0.01), suggesting the presence 
of a higher number of focal adhesion contacts in GF. 
Moreover, the counterstaining with F-actin also revealed 
a higher number of stress fibers in GF than in XF and CF. 
No differences on signal intensity in the three cell types for 
the mesenchymal marker vimentin were found. However, 
vimentin intermediate filaments displayed higher level of 
organization in GF. Finally, given its important role in 
TGFβ signaling, we also analyzed the expression of the 
cell-surface glycoprotein endoglin (or CD105), noting that 
its expression was significantly lower in GF and XF as 
compared with CF (P<0.1).
Effects of MAL-PDT in fibroblasts survival
To evaluate the effect of MAL-based PDT on the 
three fibroblasts types, cells were incubated with MAL 
Oncotarget77387www.impactjournals.com/oncotarget
(1mM) for 5 h and then exposed to different red light 
doses (from 1.8 to 16.7 J/cm2) (Figure 2A). PDT induced 
a cytotoxic effect on all cell types which was dependent 
on the red light dose, but at light doses equal or higher 
than 11.2 J/cm2 GF and XF were more sensitive to the 
treatment than CF (P<0.01). Treatment conditions that 
caused a 33,8±1,4% of cell death in GF and a 33,2±1,6% 
XF (1 mM of MAL plus 11.2 J/cm2 of red light), induced 
a 5,6±2,8% in CF.
Figure 1: Expression of CAF markers in primary dermal fibroblasts. (A) Immunofluorescence detection of α-sma, vinculin/F-
actin, vimentin and endoglin in CF, GF and XF (scale bar: 10 μm). (B) Mean intensity of the fluorescent signal of each marker, measured 
by using ImageJ (total quantified area: 4 cm2) (*: significant P<0.1; **: significant P<0.05; ***: significant P<0.01).
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PDT effects were also evident on cell morphology 
(Supplementary Figure 2A). In fact phase contrast 
microscope images showed that PDT caused cytoplasmic 
retraction and cellular stretching, indicative of cell 
degeneration processes that were more apparent in GF 
and XF.
Effects of UVA and UVB low doses in fibroblasts 
proliferation and morphology
The effect of UVA and UVB light on the 
proliferation rate of CF, GF and XF cells was assessed by 
cell counting 24, 48 and 72 h after irradiation. In general, 
both UVA and UVB applied doses led to a slight increase 
in fibroblasts proliferation, which was more marked 48 h 
after irradiation. At this time point (Figure 2B) in the case 
of UVA exposure no significant differences were observed 
between irradiated and non-irradiated CF cell percentage, 
while GF and XF irradiated cultures showed a significantly 
higher cell percentage than non-irradiated ones. Exposure 
to UVB light resulted in a significant increase of cell 
percentage in the three fibroblast types. In any case, the 
UVA and UVB low doses used did not caused apparent 
changes in cellular morphology (Supplementary Figure 
2B).
Analysis of DNA damage markers after UVA/
UVB exposure
To confirm that UVA and UVB at the doses used 
did not induce DNA damage, we analyzed the nuclear 
expression of γH2A.x, the active/phosphorylated form 
Figure 2: Effects of MAL-PDT and UV irradiation on fibroblasts survival. (A) CF, GF and XF were incubated with 1 mM of 
MAL for 5 h and then subjected to different red light doses (ranging from 0 to 17 J/cm2). Cell survival was assessed 24 h after PDT by the 
trypan blue dye exclusion assay and counting by using an Automated Cell Counter. (B) Percentages of fibroblasts present in the cultures 
48 h after UVA (500 and 1000 mJ/cm2) and UVB (21, 32 and 64 mJ/cm2) irradiation. Graphs show the significant differences between 
irradiated cultures and their corresponding non-irradiated (control) cultures (*: significant P<0.1; **: significant P<0.05; ***: significant 
P<0.01).
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of the histone H2A.X, and the formation of cyclobutane 
pyrimidine dimers (CPDs), dipyrimidine photoproducts 
induced by UV radiation, by immunofluorescence 
(Figure 3). Measurement of both markers was carried 
out 48 h after UVA (1000 mJ/cm2) and UVB (64 mJ/
cm2) exposure. These light doses did not induce γH2A.x 
expression in interphase nuclei and the signal of this 
protein was only observed in nuclei of dividing cells. 
Similarly, no CPD foci were detected in nuclei of cells 
subjected to UV low doses. However, when CF, GF 
and XF were subjected to higher UVA and UVB doses 
(4000 and 300 mJ/cm2, respectively), used as positive 
control of damage, γH2A.x signal as well as CPDs 
foci were observed in all nuclei, confirming DNA 
damage. Moreover, in the case of UVB high dose, the 
mean fluorescence of both markers was significantly 
higher in GF and XF with respect to CF. Fluorescence 
images correspond to UVB-exposed cultures. The same 
expression patterns were observed after UVA exposure 
(data not shown).
Overall, our γH2A.x and CPDs results indicate that 
light doses equal or lower than 1000 mJ/cm2 of UVA and 
64 mJ/cm2 of UVB, do not induce any detectable DNA 
repair-triggering damage on CF, GF and XF fibroblasts.
Production of reactive oxygen species (ROS) 
after UVA exposure and PDT
UV effects can be mediated by the production of 
reactive oxygen species (ROS). In the same way, ROS are 
the main cytotoxic agents triggered by PDT. Therefore, 
we analyzed the intracellular ROS concentration in CF, 
GF and XF when subjected to UVA radiation (500 or 
1000 mJ/cm2) or PDT (MAL 1mM plus 11.2 J/cm2 of red 
light) by fluorescence microscopy and flow cytometry 
(Figure 4).
A stronger signal of basal fluorescein in GF and 
XF compared with CF was observed (Figure 4A). 
Moreover, the signal was stronger after UVA exposure 
in all fibroblasts types but more clearly in GF and XF. 
Measurement of the mean fluorescence of fluorescein by 
flow cytometry (Figure 4B) confirmed the above findings: 
profiles showed that basal fluorescence was higher in 
GF and XF than in CF. UVA light induced an increase 
of fluorescence in all cell types compared to basal levels 
and it was significantly higher in GF and XF than in CF 
(P<0.05).
PDT also induced an increase in the fluorescence 
intensity of fluorescein in all cell types compared with 
baseline levels. Fluorescence values after treatment were 
significantly higher in GF and XF than in CF (P<0.05) 
(Figure 4C).
Overall, our results indicate that basal intracellular 
concentration of ROS is higher in GF and XF than in 
healthy fibroblasts. Moreover, both UVA light and PDT 
induce a higher oxidative response in GF and XF than in 
CF.
Effects of MAL-PDT in UV-photoactivated 
fibroblasts
In order to assess whether PDT is effective under 
the effects of a mild exposure to UVR, we decided to 
stimulate fibroblasts with sub-genotoxic UV doses before 
applying PDT. We selected irradiation doses of 500 and 
32 mJ/cm2 of UVA and UVB, respectively, and MAL-PDT 
treatment conditions of 1mM of MAL and 11.2 J/cm2 of 
red light, assuming that these conditions would allow an 
optimal activation of fibroblasts and a selective effect of 
PDT.
In general, after UV+PDT, the cell death rate was 
higher than after PDT alone. In the case of UVA+PDT, 
compared to PDT, the decrease of survival was only 
significant in GF and XF cells (P<0.01), while CF showed 
a low sensitivity. When PDT was applied after stimulation 
with UVB light, the decrease of survival was significantly 
higher than that achieved with PDT alone for all fibroblast 
types (P<0.01), though the survival rate was significantly 
lower in GF and XF than in CF (P<0.01). Noteworthy, 
XF cells were the most sensitive to UVB+PDT, with a 
survival rate below 10% (Figure 5A).
Although more acute, morphological changes 
observed after UV+PDT (Figure 5B) were the same to 
those described after PDT alone for all the cell types: 
cytoplasmic retraction, cellular stretching and detachment 
of cells from substrate.
DNA damage after PDT and UV+PDT
The expression of γH2A.x was analyzed 48 h after 
treatments by immunofluorescence (Figure 6A) and 
Western blot (Figure 6B). As shown Figure 6A, PDT and 
UV+PDT treatments lead to an increase in the percentage 
of γH2A.x-positive cells and in the signal intensity of this 
protein as compared to non-treated (control) fibroblasts 
(in which γH2A.x was only detected in dividing cells). 
When cells were subjected to UVA/UVB+PDT the 
amount of positive nuclei and the mean fluorescence 
were significantly increased with respect to PDT 
(P<0.01) in all fibroblast types. Moreover, percentage of 
positive cells and γH2A.x mean fluorescence after PDT 
or UV+PDT were significantly higher in GF and XF than 
in CF (P<0.01).
The results obtained by Western blot (Figure 6B) 
showed a similar trend. No expression of γH2A.x was 
observed in any of the fibroblasts types after UVA/UVB 
irradiation. In the case of CF, it was only detected after 
UV+PDT treatments, while in GF and XF both PDT 
and UV+PDT induced an increase in protein expression. 
Moreover, this increase was higher after UV+PDT than 
after PDT alone.
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Cell death mechanisms involved in PDT alone 
and after UV exposure
We evaluated if apoptosis was the main cell death 
mechanism triggered by PDT alone and after UVA/UVB 
irradiation. We first performed a TUNEL assay 24 h after 
treatments to confirm if DNA fragmentation was occurring 
(Figure 7A). TUNEL assay detected the presence of DNA 
strand breaks in all PDT and UVA/UVB+PDT treated 
cultures. The number of TUNEL-positive nuclei was 
significantly higher in GF and XF than in CF (P<0.01). 
In addition, with the exception of XF, the percentage of 
TUNEL-positive cells was significantly higher in the case 
of UVA/UVB+PDT, as compared with PDT alone.
To further analyze the putative apoptotic cell 
death mechanism after treatments, we also evaluated the 
expression of caspase 3, a key mediator of this process, 
by western blot. In general, the expression of the inactive 
form of this protein (Figure 7B) showed a tendency to 
decrease when cells were subjected to PDT and that was 
Figure 3: γH2A.x expression and CPDs formation after UVA and UVB irradiation. Cell cultures were sunjected to UVA/UVB 
low doses (1000 and 64 mJ/cm2, respectively) and UVA/UVB high doses (4000 and 300 mJ/cm2, respectively). (A) The signal of γH2A.x 
and the CPDs foci were detected by immunofluorescence. Images correspond to UVB-exposed cultures. Similar patterns were observed 
after UVA irradiation (data not shown). (B) Mean intensity of the fluorescent signals of γH2A.x and CPDs was measured using the Measure 
and Label plugin of ImageJ software (*: significant P<0.1; **: significant P<0.05; ***: significant P<0.01) (MF: mean fluorescence).
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more evident in cells subjected to UVA/UVB+PDT. This 
decrease was particularly remarkable after UVB+PDT. 
UVA and UVB irradiation alone did not induce any 
relevant difference in the expression of caspase 3, as 
compared to control cells. It can be expected that the 
decrease of the inactive form of caspase 3 was linked to 
an increase of its active forms, generated by the cleavage 
of the full-length protein.
One of the main cellular targets of active caspase 
3 is PARP (Poly ADP Ribose Polymerase), mainly 
Figure 4: Production of ROS after UVA light (A-B) and PDT (C). (A-B) Cell cultures were incubated with DHF-DA and exposed to 
UVA light (500 or 1000 mJ/cm2). Then, the fluorescent signal corresponding to fluorescein was observed using a fluorescence microscopy 
(A) and measured by flow cytometry (B) (P<0.05). (C) Cells were subjected to PDT (MAL 1mM plus 11.2 J/cm2) and the fluorescence of 
fluorescein was measured by flow cytometry (P<0.05). (Cells incubated with DHF-DA but not exposed to UVA light were used as control, 
baseline fluorescein).
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involved in DNA repair [24]. We therefore analyzed the 
expression levels of PARP after UVA/UVB, PDT and 
UVA/UVB+PDT by Western blot (Supplementary Figure 
3). In the case of CF, only the active form of the PARP 
(116 kDa) was detected, and its expression decreased 
after PDT or UVA/UVB+PDT. Conversely, the inactive 
(cleaved) form of PARP (89 kDa) was observed in GF and 
XF treated with PDT or UVA/UVB+PDT.
DISCUSSION
Minimally invasive treatments for skin cancers 
or pre-malignant lesions are highly desirable and PDT 
fulfills that modality. It is thus clinically relevant to 
achieve differential conditions enabling the elimination 
of cancer-prone cells while avoiding harmful effects 
on the unaffected tissue. Abundant evidence suggests 
that activated stromal fibroblasts play a major role in 
cancer development. Fibroblasts in the tumor stroma 
acquire a perpetually activated phenotype and become 
a subpopulation that can be identified by determined 
markers, although due to CAF heterogeneity there is a 
lack of universal markers [25–27]. Although malignancy 
is mainly associated to altered keratinocytes (i.e. in non-
melanoma skin cancer), fibroblasts may be key players in 
the pathogenesis of cancer-prone genodermatoses such as 
Figure 5: Effect of UV+PDT on fibroblasts survival and morphology. Fibroblasts were subjected to UV light (500 mJ/
cm2 of UVA or 32 mJ/cm2 of UVB) or UV+PDT treatments (500 mJ/cm2 of UVA or 32 mJ/cm2 of UVB followed by MAL 1mM plus 
11.2 J/cm2). (A) Cell survival after treatments was quantified by trypan blue dye exclusion assay and counted using and Automated Cell 
Counter (only statistical differences between PDT and UV+PDT groups are shown; P<0.01). (B) Post-treatment cell morphology was 
analyzed by microscopic observation (Olympus BX-61) (scale bar: 40 μm).
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XP and GS [19]. We have confirmed the cancer-associated 
fibroblasts (CAFs) features are present in fibroblasts 
obtained from XP and GS patients.
Alpha smooth muscle actin (α-sma), a general 
myofibroblast marker, is widely used to identify CAFs 
since they become reprogrammed variants resembling 
myofibroblasts [25–27]. Several studies have reported 
the increased expression of α-SMA in tumor surrounding 
tissue areas of facial BCCs [28] and nasopharyngeal 
carcinoma [27]. We showed here the overexpression of 
α-sma in GF and XF as compared with CF.
CAFs increase its migratory potential compared with 
normal fibroblasts [25, 29]. Cell migration is coordinated 
by a complex of proteins that localizes to sites of cell-
Figure 6: γH2A.x expression after PDT and UV+PDT. Cell cultures were subjected to UV (500 mJ/cm2 of UVA or 32 mJ/cm2 of 
UVB), PDT (MAL 1mM plus 11.2 J/cm2) or UV+PDT treatments. (A) γH2A.x was detected by immunofluorescence 48 h after treatments. 
Its expression was observed by fluorescence microscopy and the percentage of γH2A.x-positive nuclei and the signal intensity of the protein 
were measured using the ImageJ software (P<0.01) (scale bar: 30 μm) (***: significant P<0.01; δ: significant differences with respect to 
CF, P<0.01) (MF: Mean Fluorescence). (B) Post-treatment expression of γH2A.x was also quantified by Western blot (Loading control: 
GADPH).
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matrix interaction, the focal adhesions (FAs). Vinculin 
plays a role in the regulation of these complexes and 
therefore this protein has also been described as a CAF 
marker. Our results show a higher expression of vinculin 
in GF than in CF.
Mesenchymal adhesion proteins, such as vimentin, 
are upregulated in cells with migratory properties. For 
that reason, vimentin has been also used as a marker to 
detect CAFs [22, 30]. In the present study, although no 
differences were found regarding to the signal intensity of 
this protein, vimentin filaments seemed better organized 
in GF than in CF.
Endoglin (CD105), a cell-surface glycoprotein 
identified as an optimal indicator of proliferation of 
Figure 7: TUNEL assay and analysis of caspase-3. Fibroblasts were subjected to PDT (1 mM of MAL plus 11.2 J/cm2 of red 
light) or UVA/UVB irradiation (500 and 32 mJ/cm2, respectively) plus PDT. (A) TUNEL assay was performed 24 h after treatments.DNA 
fragmentation (green-stained fragments) typical of apoptotic processes was observed by fluorescence microscopy and the percentages of 
TUNEL-positive nuclei were measured using the ImageJ software (P<0.01) (scale bar: 20 μm). (B) Post-treatment expression of caspase-3 
was quantified by Western blot.Loading control: GADPH (36 kDa).
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human endothelial cells [31], was also evaluated here. 
Results showed that this protein was reduced in GF and 
XF as compared to CF. This novel finding is consistent 
with results described by Guerrero-Esteo et al. [32], which 
indicated that overexpression of endoglin in fibroblasts 
leads to decreased migration and invasion potential. 
Moreover, this was also reported by Liu et al. [33], who 
indicated that loss of endoglin expression appears to be 
associated with prostate cancer progression.
Taken together, all these results provide support to 
consider that primary fibroblasts obtained from GS and XP 
patients could be potential CAFs. In accordance to that, a 
previous study carried out by Gache et al. [19] in human 
fibroblasts obtained from skin biopsies of nevoid basal cell 
carcinoma syndrome (NBCCS) patients suggested that 
susceptibility of these patients toward BCCs development 
could be partly due to a “pre activated state” of stromal 
fibroblasts.
Our results showed a selectivity of MAL-PDT 
towards dermal fibroblasts from XP and GS patients. 
Administration of MAL at 1mM followed by 11.2 J/cm2 
of red light leads to a differential effect on fibroblasts 
viability: survival of GF and XF decreased by almost 40% 
while in CF only diminished a 5%. Several clinical trials 
carried out in Gorlin syndrome patients describe PDT as 
an interesting treatment option. Application of topical 
ALA or MAL-PDT in multiple BCCs not only reduces 
the thickness of lesions but also achieves clearance rates 
between 60-80%, with excellent cosmetic outcomes 
[34–36]. Moreover, systemic PDT using Photofrin as 
photosensitizer and interstitial optical fibers as irradiation 
source, results effective in the treatment of thicker BCCs 
(as nodular subtypes), avoiding surgery [11, 12]. In 
addition, Caty et al. [37], reported that MAL-PDT is able 
to delay de development of BCCs in PTCH heterozygous 
mice model chronically exposed to UV radiation, which 
suggest the preventive role of PDT in this type of lesions. 
In contrast to GS, there is little evidence in the literature 
supporting the use of PDT in XP patients. Larson and 
Cunningham [17] reported a case of XPC patient treated 
with ALA-PDT and blue light without adverse events. And 
a study performed by Segura et al. (2011) [18], concluded 
that MAL-PDT may be useful for the treatment of 
superficial BCCs in XP patients, with minimal secondary 
effects.
Differential impact of PDT described above 
is supported by measurements of intracellular ROS 
concentration: ROS production triggered by PDT is higher 
in fibroblasts from GS and XP patients.
We also checked if effectiveness and selectivity 
observed after MAL- PDT were maintained when cells 
were exposed to UVA, a dermis-acting radiation, and 
UVB under mild irradiation conditions. To assess for 
potential unexpected DNA/chromatin damage of UVR 
doses we analyzed γ-H2AX. This protein is a minor 
component of nuclear histone H2A involved in several 
biological processes, including specific aspects of cell 
division (structural and functional chromatin regulation 
during mitosis), stem cell biology and aging [38]. The 
phosphorylation of this histone was originally identified as 
an early event after the direct formation of DNA double-
strand breaks (DSBs) by ionizing radiation. However, the 
generation of γ-H2AX is now also considered to occur 
during DNA repair process at sites of various types of 
DNA damage, such as UV-induced photolesions [39, 
40]. Our results with this marker confirmed that UVA/
UVB doses used to activate CF, GF and XF, do not 
induce DNA damage. As pointed out above, γH2A.x is 
normally involved in cell division process, so the observed 
expression in dividing cells cannot be attributed to UV-
induced damage.
In addition, formation of CDPs is cause of UV-
induced cytotoxicity and mutagenicity, playing an 
important role in photocarcinogenesis [41]. In this 
work, CPDs evaluation confirmed that the low doses of 
UVA/UVB used to stimulate fibroblasts did not induce 
detectable damage.
Exposition to UV light and subsequent application 
of PDT to treat primary fibroblasts and keratinocytes from 
GS and XP patients has not been described. Here we show 
that GS and XP patient-derived fibroblasts (potentially 
CAFs) are more sensitive to PDT than fibroblasts from 
healthy donor not only at basal conditions but also when 
are stimulated by UVA and UVB light.
It is widely documented the involvement of 
caspase-3 in apoptosis, being a critical executor of this 
death process. Its activation take place by the proteolytic 
processing of its inactive zymogen into activated p17 
and p12 fragments [42]. On the other hand, PARP plays 
a crucial role in DNA repair and is one of the most 
important targets of caspase-3. The cleavage of PARP 
by caspase-3 inactivates it and inhibits PARP’s DNA-
repairing abilities [43]. Taking into account our results of 
TUNEL assay, it seems that the three types of fibroblasts 
undergo apoptosis when treated with PDT or UV+PDT. 
Post-treatment analysis of caspase-3 and PARP expression 
pointed out that apoptosis is the main mechanism of cell 
death. The decrease of inactive caspase-3, accompanied by 
increased expression of cleaved PARP, supports that PDT 
and UV+PDT could be inducing programmed fibroblasts 
death. Nevertheless, percentages of apoptotic figures 
found in treated cultures determined by TUNEL assay 
were lower than overall death percentages resulting from 
viability assays, so other cell death pathways could be also 
be activated.
Overall our results show susceptibility of GS and 
XP fibroblasts to PDT. Such therapeutical approach 
evaluated here in cells from genetic diseases, could be 
also beneficial for spontaneous skin tumors where CAFs 
play a significant role. The fact that these fibroblasts 
behave as CAFs is likely contributing to malignancy in 
the genodermatoses addressed in our study and, since 
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they are highly susceptible to MAL-PDT, suggest that this 
approach could not only be relevant to treat the epithelial 
component of tumors or premalignant lesions but also the 
activated stromal cells. As shown in our study, a priming 
response elicited by UVA (the one with the capacity to 
reach the dermis) may even enhance the effect of MAL-
PDT.
MATERIALS AND METHODS
Cell culture
Human dermal fibroblasts were isolated from XP 
(Xeroderma Fibroblasts, XF) and GS (Gorlin Fibroblasts, 
GF) patients. Fibroblasts obtained from three different 
healthy donors were used as control (Control Fibroblasts, 
CF). Isolation was performed according to current 
procedures [44, 45]. Fibroblasts were cultured up to eight 
passage under standard conditions in Dulbecco’s modified 
Eagle’s medium (DMEM) (Thermo Fisher Scientific Inc., 
Walthan MA USA).
Immunofluorescence
For immunofluorescence, cells were grown on 
glass coverslips, fixed with 3.7% formaldehyde in PBS 
and permeabilized in 0.1% Triton X-100 in PBS (Merck, 
Darmstadt, Germany). Then, cells were incubated with 
the primary antibodies for 1 h, washed with PBS and 
incubated with secondary antibodies for 45 min. At last, 
cells were mounted with ProLong Gold antifade with 
DAPI (Thermo Fisher Scientific Inc., Walthan MA USA). 
In the case of CPDs detection, cells were also treated with 
2M HCl for DNA denaturation before incubation with 
the corresponding primary antibody. Antibodies used for 
immunofluorescence are shown in the Supplementary 
Table 1.
UV irradiation, photodynamic therapy and 
UV+PDT treatments
When fibroblasts, seeded in 35 mm dishes (Thermo 
Scientific Inc., Walthan MA USA), reached a confluence 
of 30-40%, were washed with PBS and exposed to 
UVB/UVA light under a thin film of PBS. Lamps were 
maintained at 18 cm from cultures. UVB doses applied 
were 21, 32 and 64 mJ/cm2 and UVA doses were 500 and 
1000 mJ/cm2. Immediately after irradiation, PBS was 
replaced with fresh culture medium. The UVA source was 
a 50/60 Hz 14 VA lamp (300-400 nm; Camag Scientific, 
Muttenz, Switzerland) (Supplementary Figure 1A). The 
UVB source was a 2x15 W-312 nm tube UV lamp (270-
380 nm, Vilber Lourmat, Marne La Vallée, France) filtered 
through a colored-glass filter with a 305± 5 nm cut-on 
wavelength (Newport, Irvine, CA, USA) (Supplementary 
Figure 1B). UVB and UVA spectra and outputs were 
measured using a USB2000+ radiometer (Ocean Optics, 
Dunedin, Florida, USA).
For PDT administration, fibroblasts were 
incubated in serum-free medium containing methyl-δ-
aminolevulinic acid (MAL, Sigma Aldrich, St. Louis, 
MO, USA), a precursor of the endogenous photosensitizer 
protoporphyrin IX (PpIX), at a final concentration of 1 
mM, for 5 h and in the dark (MAL concentration and 
incubation period were previously tested and selected 
as optimal treatment conditions). Then, medium was 
replaced by fresh medium with 10% FBS and the cells 
were irradiated with different doses of red light, using 
a 384 light-emitting diode matrix (WP7143 SURC/E 
Kingsbright, wavelength 636±17 nm).
To perform the UVB/UVA+PDT treatments, cells 
were first exposed to UVB/UVA light and, 48 h after 
irradiation, subjected to MAL-PDT.
Determination of cell survival/proliferation
Cell survival was assessed by the trypan blue dye 
exclusion assay. At different time points after treatments 
adherent cells were trypsinized, collected with floating 
cells and pelleted by centrifugation (1200 rpm, 5 min). 
Then, cells were re-suspended in PBS mixed with 0,4% 
trypan blue solution (Sigma Aldrich, St. Louis, MO, USA) 
and counted by using an Automated Cell Counter TC20TM 
(BioRad, Hercules, CA, USA).
Measurement of intracellular ROS
In order to analyze the intracellular production of 
ROS after UVA irradiation or PDT, dihydrofluorescein 
diacetate (DHF-DA) assay was performed. This is a 
fluorescent probe for detecting intracellular oxidants 
because of its high reactivity toward specific oxidizing and 
one of the most common methods to detect intracellular 
ROS levels species. After incorporating into the cell, 
DHF-DA is deacetylated by cellular esterases to a non-
fluorescent compound, which is later oxidized by ROS 
giving fluorescein, a highly fluorescent compound, 
which can be detected by fluorescence microscopy or 
spectroscopy with maximum excitation and emission 
spectra of 495 nm and 529 nm, respectively [46]. A 
stock 0.5 mM of DHF-DA (Abcam) in absolute ethanol 
was prepared. Work solution for cell incubation was a 
dilution from this stock in DMEM without FBS to a final 
concentration of 6 μM. For detecting ROS after UVA 
irradiation, fibroblasts were seeded in 100 mm culture 
dishes and maintained in the incubator until they reached 
a confluence of 80-90%. Then, cells were incubated for 50 
min with 6 μM of DHF-DA. At the end of the incubation 
period and without removing DHF-DA, cells were exposed 
to UVA light (500 or 1000 mJ/cm2). Fibroblasts incubated 
with DHF-DA but not exposed to UV radiation were 
used as DHF-DA control. Immediately after irradiation, 
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cells were analyzed by fluorescence microscopy, under 
blue excitation light, or were washed twice with PBS, 
trypsinized with Trypsin-EDTA 0.05% and centrifuged 
for 10 min at 2000 r.p.m. The pellet was fixed for 15 min 
in 3.7% formaldehyde/PBS solution, centrifuged for 5 min 
at 2000 r.p.m. and resuspended in PBS. Fluorescence of 
fluorescein was measured by flow cytometry (Cytomics 
4500). For detection of ROS after PDT, cells were seeded 
in 25 cm2 culture flasks and incubated with 1mM of MAL 
for 5 h in the dark. DHF-DA 6 μM was administered in 
the last 50 min and finally cells were exposed to 11.2 J/
cm2 of red light. After irradiation, cells were processed and 
fluorescein fluorescence was measured as described above.
DNA fragmentation assay
Terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) assay was used to determine DNA 
fragmentation. At specific points after treatments, cells 
were washed with PBS, fixed with 3.7% formaldehyde 
and permeabilized in 0.1% Triton X-100/PBS. DNA 
ends were labeled with an in situ cell death detection kit 
(Roche, Risch-Rotkreuz, Switzerland) for 1 h at 37°C and 
the samples were mounted as for immunofluorescence.
Western blot
Twenty-four hours after treatments, cells were lysed 
with RIPA buffer (BioWorld, Dublin, OH, USA) containing 
phosphatase and protease inhibitor cocktails (Roche, 
Risch-Rotkreuz, Switzerland). The samples were adjusted 
to the same protein concentration (BCA protein assay kit, 
Pierce, Rockford, IL, USA) and denatured by boiling in 
Laemmli sample buffer with 5% β-mercaptoethanol. Then 
were subjected to electrophoresis separation in SDS-
PAGE. Gels were transferred to a PVDF membrane using 
a Trans-Blot turbo transfer system (BioRad, Hercules, 
CA, USA) and membranes were blocked with 5% nonfat 
milk in Tris-buffered saline (TBS) with 0.1% Tween 
20, for 2 h. After blocking, membranes were incubated 
overnight with specific primary antibodies and then with 
HRP-conjugated secondary antibodies (Supplementary 
Table 1) and developed by chemiluminiscence (ECL, 
Thermo Fisher Scientific Inc., Walthan MA USA) using a 
ChemiDoc system (BioRad, Hercules, CA, USA). Bands 
corresponding to the different proteins were quantified, 
digitalized and analyzed with Image Lab 2.0.1. software 
(BioRad, Hercules, CA, USA) and Adobe PhotoShop CS5 
12.0 (Adobe Systems Inc., USA).
Microscopic observations, quantification and 
statistical analysis
Microscopic observation was realized using a 
fluorescence microscope (Olympus BX-61) equipped with 
the following filter sets: ultraviolet (UV, 365 nm, exciting 
filter UG-1), blue (450−490 nm, exciting filter BP 490), 
green (545 nm, exciting filter BP 545) and red (620-700 
nm, exciting filter CC50R). Images were obtained with the 
digital camera Olympus CCD DP70 and processed using 
the Adobe PhotoShop. To quantify the expression of CAF 
markers, mean fluorescence signal intensity of each marker 
in a total area of 4 cm2 was measured. Measurement was 
performed from microscopy images, using the Measure 
and Label plugin of ImageJ 1,43u (NIH, USA). In the case 
of CPDs, γ-H2AX and TUNEL assay, positive nuclei for 
these markers were counted (from a total of 800 nuclei of 
each treatment condition) from microscopy images using 
the Cell Counter plugin of ImageJ 1.50b (NIH, USA). 
Moreover, mean fluorescence per nucleus was quantified 
too through ImageJ.All experiments were carried out 
using three replicates in three independent experiments. 
The results were processed using software SPSS Statistics 
20.0 (IBM®). Data are expressed as the mean value ± 
standard deviations (SD). The statistical significance was 
determined using the analysis of variance (ANOVA) and t 
test (*: P<0.1; **: P<0.05; ***: P<0.01).
Abbreviations
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light B), PDT (photodynamic therapy), MAL (methyl 
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